Klotho Neurosciences, Inc. (KLTO) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 1.85M | 1.89M | 1.59M | 1.85M | 2.87M | 395.61K | 672.04K | 110.73K | 123.74K | 244.25K |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.58M | 1.65M | 1.59M | 1.85M | 2.87M | 395.61K | 672.04K | 110.73K | 123.74K | 244.25K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 271.14K | 238.7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.85M | -1.89M | -1.59M | -1.85M | -2.87M | -395.61K | -672.04K | -110.73K | -123.74K | -244.25K |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 35.45% | -378.47% | -136.14% | -1572.18% | -2220.19% | -61.97% | - | - | - | - |
| EBITDA | -1.72M | -2.33M | -1.68M | -1.77M | -2.91M | -436.57K | -672.04K | -110.73K | -123.73K | -244.23K |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 41.07% | -434.43% | -149.99% | -1499.05% | -2255.47% | -78.75% | - | - | - | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -1.72M | -2.33M | -1.68M | -1.77M | -2.91M | -436.57K | -672.04K | -110.73K | -123.73K | -244.23K |
| Net Interest Income | -1.18M | -1.76M | -553.94K | -296.58K | -44.96K | -15.06K | 0 | -15.74K | -20.38K | -20.16K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.18M | 1.76M | 553.94K | 296.58K | 44.96K | 15.06K | 0 | 15.74K | 20.38K | 20.16K |
| Other Income/Expense | -1.04M | -2.2M | -647.01K | -215.61K | -88.49K | -56.03K | 1 | -15.74K | -20.37K | -20.14K |
| Pretax Income | -2.9M | -4.09M | -2.23M | -2.07M | -2.96M | -451.64K | -672.04K | -126.47K | -144.11K | -264.39K |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2.9M | -4.09M | -2.23M | -2.07M | -2.96M | -451.64K | -672.04K | -126.47K | -144.11K | -264.39K |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 2.16% | -806.31% | -232.42% | -1534.52% | -1953.57% | -70.82% | - | - | - | - |
| Net Income (Continuing) | -2.9M | -4.09M | -2.23M | -2.07M | -2.96M | -451.64K | -672.04K | -126.47K | -144.11K | -264.39K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.05 | -0.12 | -0.08 | -0.08 | -0.18 | -0.03 | -0.00 | -0.01 | -0.00 | -0.02 |
| EPS Growth % | 72.94% | -316.67% | - | - | - | -65.52% | - | - | - | - |
| EPS (Basic) | -0.05 | -0.12 | -0.08 | -0.08 | -0.18 | -0.03 | -0.00 | -0.01 | -0.00 | -0.02 |
| Diluted Shares Outstanding | 59.42M | 33.95M | 27.52M | 27.08M | 16.69M | 15.68M | 1.04B | 1.04B | 1.04B | 1.04B |
| Basic Shares Outstanding | 59.42M | 33.95M | 27.52M | 27.08M | 16.69M | 15.68M | 1.04B | 1.04B | 1.04B | 1.04B |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |